Mr. Lohmeyer has been an operations and finance executive for global businesses in a variety of industries. In addition to his work with MMW, he is the Chief Financial Officer (CFO) of Cloud Pharmaceuticals, Inc., a pioneer and leader in silico drug design using artificial intelligence and the massive computing resources of the cloud. Previously he was with AAI Pharmaceuticals, Inc., initially as CFO and then CEO. AAI was a global Clinical Research Organization (CRO) operating in Stage 1 to 3 drug research, drug formulation, solid and sterile drug manufacturing and lab operations. Prior to AAI, he was CFO and then CEO of Energy Conversion Systems , a global private equity owned business in engineered materials.
He began his career in Public Accounting with PricewaterhouseCoopers and then joined Fortune 500 global firms in manufacturing and distribution. Seeking a more entrepreneurial career in technology-based businesses, he began working for high growth, early stage companies in the 1990’s. He has completed 25 M&A transactions, raised both equity and debt and was responsible for completing the exits of both ECS and AAI. Mr. Lohmeyer received a Bachelor of Science from Purdue University, a Master in Management from Northwestern’s Kellogg School of Management and is a Certified Public Accountant. More information on his background is at: https://linkedin.com/in/lylelohmeyer/.